Orthostatic Intolerance in Autonomic Neuropathies & Postural Tachycardia Syndrome

自主神经病的直立不耐受

基本信息

  • 批准号:
    7892374
  • 负责人:
  • 金额:
    $ 24.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The Mayo Autonomic Disorders PPG was the first autonomic disorders program project funded by NIH. In the 9 years since its inception, we have continued our focus on orthostatic intolerance and failure. Orthostatic intolerance can be unassociated with OH as in POTS. Over the past 10 years we have assembled a unique combination of personnel, patients, and instruments to facilitate the series of important studies we are proposing; some of which can only be done at Mayo. POTS: At the inception of this PPG, little information was available on the pathophysiology of POTS. Orthostatic intolerance without OH occurs much more commonly than OH in a ratio of approximately 5:1.46'47 Over the last 4 years of the current cycle, significant progress has been made in this and other autonomic programs. We reported that about 50% of POTS may be post-infectious suggesting an immune-mediated limited autonomic neuropathy. ' Since that time, the clinical features have been prospectively evaluated using a standardized instrument.58 Independent clinical and laboratory features that aid the diagnosis of POTS have been defined and its outcome evaluated.51 We have, for the first time, developed a validated instrument to evaluate autonomic symptoms.73 Significant advances have also been made on its pathophysiology. Peripheral denervation has been confirmed, and about 10% have ganglionic antibody.76 Norepinephrine spillover in the leg is reduced by 50% in POTS31 and there is denervation supersensitivity of the lower extremity veins.71 Sudomotor denervation is present in the distal lower extremity.26'48 Denervation results in an increase in vascular capacity manifested as increased venous pooling48'66 and a reduction in preload.47 Excessive venous pooling and/or a reduced plasma volume results in a hyperadrenergic state29 and there may be a component of p-receptor supersensitivity.69 Cerebral hypoperfusion occurs during HUT but not during supine rest, in part due to hypocapnia.53 HUT results in a large but transient fall in BP, with recovery within 30 seconds. During this interval, the depth but not rate of respiration increases53 and pCO2 falls resulting in a large fall in cerebral perfusion. Reversing hypocapnia with rebreathing CO2 will normalize cerebral perfusion.53 POTS is heterogenous in its manifestations. The term mild orthostatic intolerance is often applied to a heterogeneous group of subjects that include constitutional orthostatic intolerance, deconditioning, and mild hypovolemia. A hyperadrenegic state is typical,29'32'47'61 characterized by a heart rate increment >30 bpm, an absolute orthostatic heart rate >120 b.p.m, orthostatic plasma norepinephrine >600 pg/ml and is the most likely group to have reduced plasma volume. There is commonly some evidence of peripheral denervation and sometimes the term neuropathic POTS is used. Baroreflex vasoconstriction is often reduced or absent on the Valsalva maneuver47'61 and total systemic resistance is reduced.68 Pressor response to tyramine is reduced and response to phenylephrine increased, suggestive of postganglionic denervation.32 Symptoms suggestive of dysregulation are also seen, manifested as excessive increases in diastolic BP, excessive oscillations in BP on HUT, and spontaneous episodes of dysautonomia.48 It has been .suggested that these patients have a brain-stem disorder. One patient responded dramatically to decompression of the rostral ventrolateral medulla.46'48 Vasomotor, especially venomotor, tone can be impaired in an autonomic neuropathy.61 Excessive sequestration of labeled protein was demonstrated in the calves with standing, correctable by venous compression.48'70 An excessive fall in enddiastolic volume on head-up tilt (HUT) also suggests venous pooling.47 Venous pooling would result in a reduction in preload and excessive baroreceptor unloading in the upright position, with a resultant increase in sympathetic outflow. HUT results in excessive transcapillary efflux in POTS 7 and can be reflected in a progressive fall in plasma volume with continuation of standing.15 Venous occlusion plethysmography has been utilized to separately evaluate the venous and capillary components of fluid segregation and transfer. When the limb is occluded above venous pressure, the increase in limb volume evolves through two phases. There is an initial volume increase that corresponds to venous filling. This phase is followed by a slower phase representing net capillary filtration.22 A large increase in orthostatic norepinephrine is well documented in POTS (see above). Less well known is that orthostatic and supine epinephrine can also be increased in POTS. The vasoreactivity of (32-adrenoreceptors to epinephrine is important in orthostatic preload. Of particular interest is the relationship between certain polymorphisms of $2- adrenoreceptors and function. Significant interest has focussed on the relationship between two common polymorphisms, one at codon 16 and one at codon 27, on agonist-mediated vasodilatation and desensitization in the venous bed. Subjects who were homozygous for Argl6 had almost complete desensitization; venodilatation in response to isoproterenol in this group returned to normal much more quickly than subjects who were homozygous for Glyl6 who had more sustained venodilation.9 Subjects who were homozygous for Glu27 had higher maximal venodilatation in response to isoproterenol than those who were homozygous for Gln27. Some investigators have expanded interest from single nucleotide polymorphisms (SNPs) to chromosomally phased SNPs (haplotypes).11 The distribution of some haplotypes are quite different in Caucasian, African-American, Asian, and Hispanic-Latino ethnic groups with >20-fold differences among the frequencies of the four major haplotypes. Functional differences were shown to be more dependent on haplotype pairs than to individual SNPs. The results indicate that the unique interactions of multiple SNPs within a haplotype ultimately can affect biologic and therapeutic phenotype. Applied to POTS, and based on our preliminary data, it appears that there is an overrepresentation of a certain haplotype that results in sustained venodilatation (preliminary data). We will systematically explore the relationship among the interplay of epinephrine, polymorphic (32AR with its association with resistance to agonist-mediated desensitization leading to prolonged vasodilatation, and studies on veins and HUT indices.
梅奥自主神经紊乱PPG是第一个由NIH资助的自主神经紊乱项目。在这9年里

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PHILLIP A LOW其他文献

PHILLIP A LOW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PHILLIP A LOW', 18)}}的其他基金

Phase 1 Study of Autologous Mesenchymal Stem Cell in Multiple System Atrophy
自体间充质干细胞治疗多系统萎缩的一期研究
  • 批准号:
    8925780
  • 财政年份:
    2014
  • 资助金额:
    $ 24.84万
  • 项目类别:
project 4 - Autonomic Rare Diseases Clinical Research Consortium
项目 4 - 自主神经罕见疾病临床研究联盟
  • 批准号:
    7901214
  • 财政年份:
    2009
  • 资助金额:
    $ 24.84万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7640799
  • 财政年份:
    2008
  • 资助金额:
    $ 24.84万
  • 项目类别:
Orthostatic Intolerance in Autonomic Neuropathies & Postural Tachycardia Syndrome
自主神经病的直立不耐受
  • 批准号:
    7640795
  • 财政年份:
    2008
  • 资助金额:
    $ 24.84万
  • 项目类别:
Orthostatic Intolerance in Autonomic Neuropathies & Postural Tachycardia Syndrome
自主神经病的直立不耐受
  • 批准号:
    6901514
  • 财政年份:
    2005
  • 资助金额:
    $ 24.84万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    6901518
  • 财政年份:
    2005
  • 资助金额:
    $ 24.84万
  • 项目类别:
PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PARKINSON'S DISEASE
多系统萎缩、帕金森病患者
  • 批准号:
    7206153
  • 财政年份:
    2005
  • 资助金额:
    $ 24.84万
  • 项目类别:
DEVELOPMENT OF TESTS OF AUTONOMIC FUNCTION, LABORATORY EVALUATION
自主功能测试、实验室评估的发展
  • 批准号:
    7206062
  • 财政年份:
    2005
  • 资助金额:
    $ 24.84万
  • 项目类别:
PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE USING MSNA
使用 MSNA 进行直立不耐受的病理生理学
  • 批准号:
    7206091
  • 财政年份:
    2005
  • 资助金额:
    $ 24.84万
  • 项目类别:
PHARMACOLOGIC DISSECTION OF BP CONTROL IN MSA, PD AND PD_AF: EFFECT OF GANGLION
MSA、PD 和 PD_AF 中血压控制的药理学剖析:神经节的作用
  • 批准号:
    7206138
  • 财政年份:
    2005
  • 资助金额:
    $ 24.84万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 24.84万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了